Nowa metoda oceny wrażliwości bakterii na działanie bakteriofagów opracowana we współpracy Proteon Pharmaceuticals i Instytutu Biologii Medycznej PAN
Scientists from Proteon Pharmaceuticals S.A., in collaboration with researchers from the Institute of Medical Biology Polish Academy of Sciences, have developed a new quantitative method for
Proteon Pharmaceuticals publikuje nowe badania nad strukturą ogonka bakteriofaga
Our researchers have recently published their latest article in Frontiers in Microbiology, a paper titled “Revisiting Phage Tail Spike Architecture: Evidence for Undetected Receptor-Binding Proteins
BAFASAL® otrzymuje autoryzację Unii Europejskiej jako pierwszy zootechniczny dodatek paszowy oparty na bakteriofagach dla drobiu
Proteon Pharmaceuticals is pleased to confirm that BAFASAL®, its pioneering bacteriophage-based feed additive, has received full regulatory approval from the European Union for use in
BAFASAL® coraz bliżej uzyskania autoryzacji na rynku UE
Following the Standing Committee on Plants, Animals, Food and Feed (PAFF Committee) recent meeting in Brussels, Proteon Pharmaceuticals is pleased to share a significant development
Naturalne rozwiązania bakteriofagowe dla wyzwań akwakultury
A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a
Nowatorskie Rozwiązanie w Diagnostyce APEC – Wyniki Badań Naukowych
A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains